Achives from Author

FDA proposes rule to notify women with dense breasts about increased cancer risk and imprecise mammograms

By editor
April 2, 2019

The FDA is proposing a rule for breast cancer screenings that would require doctors to give women more information about the risks associated with dense breasts.  Read the full article here.

Caduceus Chief Medical Officer, Gregg DeNicola MD, shares his take for our patients.

“Informing women that their amount of breast density may affect results of the mammogram and their risks be outlined just makes common sense; it’s hard to imagine any body opposing this recommendation. Yes; it is more time necessary to advise patients as the physician, but it is essential women are educated on the details of their mammogram.  In California, such a requirement already exists and is enforced so it will have little impact for our patients, but to set this as a national standard is just smart medicine.”


Hormone replacement therapy for women- Is it right for you?

By editor
February 12, 2019

There have been many recent articles and online buzz about hormone replacement therapy for women and our Chief Medical Officer and Caduceus physician Gregg DeNicola MD wanted to weigh in on the discussion.

Sign with Hormone Replacement Therapy on itTo provide some perspective, in 2002, an extensive study of over 16,000 women supported by the National Institutes of Health, was halted after discovering that the drugs, a combination of estrogen and progestin, caused small increases in breast cancer, heart attacks, strokes and blood clots. Those risks outweighed the drugs’ benefits -a small decrease in hip fractures and a decrease in colorectal cancer. A year later a comparable study was also stopped in the UK after comparable findings.

Chief Medical Officer Dr. DeNicola agrees, “The fact is a large, prospective study has never been executed proving hormone replacement therapy is indeed safe.  This is an emotional issue and the data is definitely conflicting. Both sides have ample data to support their position.  At Caduceus, we do not routinely recommend or dissuade the use of HRT. The decision is individualized after discussion between the patient and provider. Until the evidence is more definitive, it is the most prudent policy for our patients.”

More questions?  Schedule an in-office or virtual video chat with your Caduceus provider.


Millions of Americans incorrectly think they have food allergies, study finds

By editor
January 15, 2019

Sign that says food allergies surrounded by foodYou may have read the story recently that new research suggests Americans may be over-diagnosing themselves with food allergies. A study published in the medical journal JAMA Network Open estimates that nearly 19 percent of adults think they have food allergies, but less than 11 percent actually do.

Caduceus Chief Medical Officer Gregg Denicola MD adds, “I have felt this way for a long time and agree less than 10 percent of Americans have documented food allergies.  Most allergies are to fish and nuts.  (more…)


New Peanut Allergy Drug Shows ‘Lifesaving’ Potential

By editor
November 18, 2018

The word Allergy on top of peanutsResults from a new study may lead to approval of what could be the first drug that ameliorates potentially deadly reactions in children with severe peanut allergies.  Caduceus physician and Chief Medical Officer Gregg DeNicola MD weighs in, “I agree with the spirit of the article; a breakthrough and very promising, but not necessarily a cure. Peanut allergy sufferers will need to abstain until further evidence can support the findings.”

https://www.nytimes.com/2018/11/18/well/live/new-peanut-allergy-drug-shows-lifesaving-potential.html\

 


Colorectal cancer screening? To screen or not to screen before 50?

By editor
June 8, 2018

As CMO for Caduceus Medical Group, Gregg Denicola MD agrees that colon cancer is striking at a younger age than previous years.  Especially in high-risk populations, earlier screening may be beneficial.

He shares that the data that the American Cancer Society is using appears to be somewhat mixed and does not definitively show a benefit for screening prior to age 50. Also he notes, there would be increased costs in earlier screening recommendations and whether finding a cancer a few years earlier would decrease mortality has not been proven effective. (more…)


Current 2022 Caduceus Screening and Testing Guidelines

By editor
May 18, 2018

Our physicians, Medical Director Nathaniel DeNicola MD, and Chief Medical Officer Gregg DeNicola MD recommend the following medical screenings and testing for our patients this year:

ROUTINE LAB TESTING-

Ages 21,30,35, and every other year between 40 and 50, and annually over 50. (including lipids, A1C, PSA, thyroid, blood count and general chemistries).

PAP SMEARS-

Age 21, then ACOG guidelines: Age 21-29: Pap every 3 years, HPV not recommended.

Age 30-65: Pap & HPV every five years.

MAMMOGRAMS-

Every other year starting at age 40 until age 50 and then annually. Acceptable to stop at age 75.

COLONOSCOPY-

Every 10 years beginning at age 45. Acceptable to stop at age 75.

DEXASCAN-

In females every 1-2 years after menopause or age 50, whichever is first.

ABDOMINAL AORTIC ANEURYSM-

Screening abdominal ultrasound for men ages 65-75 with a history of tobacco use.

SKIN CHECKS-

Annually if you are a high risk (otherwise it will be part of your annual physical exam)- History of severe atypia, personal history of skin cancer, first degree relative with melanoma, history of prolonged sun exposure or sunburns, fair skin, blonde/red hair or blue/green eyes.